4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000028
SVP, GEN COUNSEL & CORP SEC sold 1,667 shares at an average $76.37 ($127,304)
- SVP, GEN COUNSEL & CORP SEC acquired 1,667 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-07-01 | Option exercise 10b5-1 | +1,667 | $21.41 | $35,690 | 32,493 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-07-01 | Sale 10b5-1 | −913 | $75.93 | $69,322 | 31,580 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-07-01 | Sale 10b5-1 | −754 | $76.90 | $57,982 | 30,826 | D |
| Derivatives | |||||||
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2024-07-01 | Option exercise · Stock Option (right to buy) 10b5-1 | −1,667 | 183,331 | D | ||
| Open-market sales · 1,667 sh · avg $76.37 · $127,304 | |||||||
Loading xslF345X05/wk-form4_1719951462.xml…